Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editing treatments for cystic fibrosis. . . . → Read More: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy
|
|||||
|
       
  |
First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy at a specific dosage, cleared their SARS-CoV-2 viruses within 11 days. . . . → Read More: Early Trial Results Show Antibody Treating Covid-19 
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds 
Gilead Sciences is acquiring biotechnology company Immunomedics, specializing in immunotherapies for cancer and other diseases, in a deal valued at $21 billion. . . . → Read More: Gilead Acquires Cancer Therapy Biotech for $21B 
A new enterprise formed to discover human therapeutic antibodies is partnering with a synthetic biology company to discover Covid-19 antibody treatments. . . . → Read More: Antibody Discovery Company Forms, Partners on Covid-19 
In a joint statement today, CEOs of nine companies promised to follow the highest ethical and scientific standards in development and testing of their Covid-19 vaccines. . . . → Read More: Biotechs, Pharmas Vow Not to Rush Covid-19 Vaccines 
Global drug makers Sanofi and GlaxoSmithKline are starting a clinical trial testing a vaccine to prevent Covid-19 infections among healthy adults in the U.S. . . . → Read More: Sanofi, GSK Begin U.S. Covid-19 Vaccine Trial  Comments are closed  Joint ventures/collaborations, New products  biomedical, biotechnology, clinical trials, Covid-19, Europe, life sciences, pharmaceuticals, U.K. 
A company developing synthetic genetic materials and proteins says independent tests show its artificial antibodies neutralize infection mechanisms in Covid-19 viruses. . . . → Read More: Synthetic Antibodies Neutralize Covid-19 Virus Proteins One comment - (Comments are closed) New products biomedical, biotechnology, chemistry, Covid-19, engineering, genomics, life sciences, nanotechnology, pharmaceuticals, physical sciences, university 
Global drug maker AstraZeneca is starting its late-stage Covid-19 vaccine clinical trial in the U.S., with a vow not to cut corners in its processes. . . . → Read More: Late-Stage Covid-19 Vaccine Trial Underway in U.S. 2 comments - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Covid-19, FDA, genomics, life sciences, pharmaceuticals, U.K., university 
Aimmune Therapeutics Inc., a developer of food allergy drugs, was acquired today by global consumer products company Nestlé for $2.6 billion. . . . → Read More: Food Allergy Biotech Acquired for $2.6B One comment - (Comments are closed) Finance biomedical, biotechnology, equity, Europe, FDA, investment, life sciences, merger, pharmaceuticals |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||